The Atrial Natriuretic Peptide Receptor 1 pipeline drugs market research report outlays comprehensive information on the Atrial Natriuretic Peptide Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Atrial Natriuretic Peptide Receptor 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Cardiovascular, Genito Urinary System, and Undisclosed which include the indications Congestive Heart Failure (Heart Failure), Resistant Hypertension, Acute Renal Failure (ARF) (Acute Kidney Injury), Contrast Induced Nephropathy, and Unspecified. It also reviews key players involved in Atrial Natriuretic Peptide Receptor 1 targeted therapeutics development with respective active and dormant or discontinued products.
The Atrial Natriuretic Peptide Receptor 1 pipeline targets constitutes close to ten molecules. Out of which, approximately nine molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase II, Phase I, Phase 0, and Discovery stages are 4, 2, 1, and 2 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Atrial Natriuretic Peptide Receptor 1 overview
The ANP receptor–guanylate cyclase molecule is a transmembrane protein that contains an extracellular ANP-binding domain and an intracellular guanylate cyclase catalytic domain. ANP activation of the ANP catalytic receptor will stimulate its intracellular guanylyl cyclase activity to convert GTP to cGMP. cGMP will then stimulate cGMP-dependent protein kinase (PKG), which will then induce smooth muscle relaxation.
For a complete picture of Atrial Natriuretic Peptide Receptor 1’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.